Charles Schwab Investment Management Inc. raised its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 0.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,595,245 shares of the company’s stock after acquiring an additional 11,750 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.56% of Colgate-Palmolive worth $477,032,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Main Street Research LLC grew its position in Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after acquiring an additional 100 shares during the last quarter. Advisor OS LLC lifted its holdings in Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after buying an additional 101 shares during the period. BLB&B Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 2.5% during the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after buying an additional 104 shares in the last quarter. D Orazio & Associates Inc. increased its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares in the last quarter. Finally, ZWJ Investment Counsel Inc. boosted its position in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock worth $349,000 after purchasing an additional 109 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on CL shares. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Thursday, November 14th. Morgan Stanley upped their price target on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Sanford C. Bernstein upped their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a report on Tuesday, July 30th. Finally, Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $105.11.
Colgate-Palmolive Stock Up 0.5 %
Shares of NYSE CL opened at $94.37 on Friday. The business has a 50-day moving average of $98.32 and a two-hundred day moving average of $98.50. The company has a market capitalization of $77.10 billion, a price-to-earnings ratio of 27.04, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.12%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.34% of the company’s stock.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- The Role Economic Reports Play in a Successful Investment Strategy
- Top 3 Financial Stocks Set to Gain From Looser Regulations
- How to Most Effectively Use the MarketBeat Earnings Screener
- Can BioMarin Stock Live Up to Wall Street’s High Expectations?
- 3 Warren Buffett Stocks to Buy Now
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.